PET/CT in Cancer: An Interdisciplinary Approach to Individualized Imaging, 1e (EPUB)

PET/CT in Cancer: An Interdisciplinary Approach to Individualized Imaging, 1e

by Mohsen Beheshti MD FASNC FACE, Werner Langsteger MD FACE, Alireza Rezaee MD ABNM

Product Details:

  • Hardcover: 276 pages
  • Publisher: Elsevier; 1 edition (June 26, 2017)
  • Language: English
  • ISBN-10: 0323485677
  • ISBN-13: 978-0323485678
  • Amazon Price: $99.99
  • Points to download: 50 Points
  • Format: EPUB
  • File Size: 198.3 MB
  • Download link below.

Download Link:

This post contains protected content. You must be logged in and have 50 points to unlock it.


Edited, authored, and reviewed by an expert team of oncologists and nuclear physicians/radiologists, this one-of-a-kind title helps you make the most of the critical role PET/CT plays in cancer staging and therapeutic responses to individualized treatments. Drs. Mohsen Beheshti, Werner Langsteger, and Alireza Rezaee place an emphasis on cutting-edge research and evidence-based practice, ensuring that you’re up to date with every aspect of this fast-changing field. For each tumor entity, you’ll find authoritative discussions of background, pathology, common pattern of spread, TNM classification, clinical guidelines, discussion, evidence-based recommendations, key points, and pitfalls.Contains 130 teaching cases with high-quality PET/CT images. Presents clear, practical guidance from multiple experts across subspecialties: nuclear medicine, oncology, oncologic surgery, radiation oncology, and clinical research. Includes separate, comprehensive chapters on head and neck, lung, breast, esophageal/gastric, pancreas/neuroendocrine, colorectal, hepatobiliary, lymphoma, gynecologic, prostate, melanoma, and brain cancers. Features short reviews of clinical aspects of different cancers, primary diagnostic procedures, and recommendations regarding PET/CT from ESMO and NCCN. Helps to reveal positive outcomes or potential deficits or weaknesses in an individual plan of care, allowing for better outcomes in patient care, future cancer research, and application of radiotracers beyond 18F-FDG.

Written by 

Leave a Reply

Your email address will not be published. Required fields are marked *